| Literature DB >> 29678964 |
Pratik Shah1, Gregory Yauney1, Otkrist Gupta1, Vincent Patalano Ii2,3, Mrinal Mohit1, Rikin Merchant4, S V Subramanian5.
Abstract
OBJECTIVES: Technology-enabled non-invasive diagnostic screening (TES) using smartphones and other point-of-care medical devices was evaluated in conjunction with conventional routine health screenings for the primary care screening of patients.Entities:
Keywords: glaucoma; primary care; telemedicine
Mesh:
Year: 2018 PMID: 29678964 PMCID: PMC5914894 DOI: 10.1136/bmjopen-2017-018774
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study design. Flow chart for overall screening procedure.
Results of routine health screenings and technology-enabled screenings
| Female | Male | Total | ||||
| Abnormal | Tested | Abnormal | Tested | Abnormal | Tested | |
|
| ||||||
| High BMI | 75 (38.9) | 193 | 121 (40.2) | 301 | 196 (39.7) | 494 |
| Low BMI | 42 (21.8) | 193 | 47 (15.6) | 301 | 89 (18.0) | 494 |
| High BP | 26 (14.5) | 179 | 62 (22.5) | 276 | 88 (19.3) | 455 |
| Low BP | 3 (1.7) | 179 | 1 (0.4) | 276 | 4 (0.9) | 455 |
|
| ||||||
| Low blood oxygen | 5 (2.8) | 179 | 14 (5.1) | 276 | 19 (4.2) | 455 |
| Single-lead ECG | 0 (0.0) | 168 | 1 (0.4) | 262 | 1 (0.2) | 430 |
| Oral | 109 (68.1) | 160 | 151 (60.2) | 251 | 260 (63.3) | 411 |
| Retinal | 5 (3.0) | 169 | 4 (1.7) | 235 | 9 (2.2) | 404 |
| Tympanic membrane | 17 (13.5) | 126 | 25 (12.6) | 198 | 42 (13.0) | 324 |
| Hand tremor | 0 (0.0) | 127 | 0 (0.0) | 186 | 0 (0.0) | 313 |
| Finger–nose | 0 (0.0) | 123 | 3 (1.6) | 182 | 3 (1.0) | 305 |
| Finger count | 0 (0.0) | 122 | 0 (0.0) | 177 | 0 (0.0) | 299 |
| Gait | 1 (1.0) | 104 | 4 (3.6) | 110 | 5 (2.3) | 214 |
Numbers and percentages (in parentheses) of males and females with conditions identified by routine health screenings and technology-enabled screenings.
BMI, body mass index; BP, blood pressure.
Figure 2Representative images of labelled conditions detected in technology-enabled screenings (TES). (A) Normal images for TES. Left to right, top to bottom: dental, periodontal, tympanic membrane, optic nerve. (B) Labelled conditions for TES. Left to right, top to bottom: caries, missing teeth, periodontal disease, perforated eardrum, effusion, width of optic rim 0.01–0.1.
Number of subjects identified with a clinical condition by a technology-enabled screening test and responded yes to a medical history question
| Hypoxaemia (19) | TM (42) | Retinal (9) | Oral (260) | Finger-nose (3) | Gait (5) | |
| Glasses | 7 | 22 | 6 | 145* | 1 | 1 |
| Dental | 9 | 14 | 5 | 82* | 1 | 4* |
| Swollen joints | 3 | 14 | 4 | 85* | 3* | 4* |
| Hearing | 5 | 17 | 4 | 72* | 2 | 3 |
| FH diabetes | 2 | 7 | 2 | 41 | 0 | 1 |
| FH high BP | 0 | 6 | 2 | 31** | 0 | 0 |
| Tobacco | 3 | 3 | 0 | 27 | 1 | 0 |
| Difficulty walking | 3 | 5 | 3* | 36* | 3* | 1 |
| High BP | 0 | 5 | 1 | 30 | 0 | 0 |
| Diabetes | 0 | 4 | 0 | 23 | 0 | 0 |
| High BP Rx | 0 | 4 | 1 | 24* | 0 | 0 |
| Asthma | 3 | 3 | 0 | 15 | 1 | 0 |
| Smoking | 4* | 1 | 0 | 13 | 0 | 1 |
| FH cardiac | 0 | 2 | 0 | 7 | 0 | 0 |
| Cardiac Rx | 1 | 1 | 1 | 8* | 0 | 0 |
| Cardiovascular | 0 | 1 | 1 | 4 | 0 | 0 |
| Low BP | 0 | 0 | 0 | 3 | 0 | 0 |
| FH stroke | 0 | 1 | 0 | 2 | 0 | 0 |
| FH eye disease | 0 | 0 | 0 | 3 | 0 | 0 |
| Heart attack | 0 | 0 | 0 | 3 | 0 | 0 |
| Coronary bypass | 0 | 0 | 0 | 3 | 0 | 0 |
| Drinking | 0 | 0 | 0 | 1 | 0 | 0 |
| Eye treatment | 0 | 0 | 0 | 2 | 0 | 0 |
| Memory loss | 0 | 0 | 0 | 2 | 0 | 0 |
| Ear treatment | 0 | 1 | 0 | 1 | 0 | 0 |
| FH ear disease | 0 | 0 | 0 | 1 | 0 | 0 |
Total populations, in parentheses, reflect the number of subjects with the particular condition in that column identified by technology-enabled screenings. Multiple subjects were associated with more than one condition or questionnaire response.
*P<0.05, subjects are more likely to have responded yes to the column’s question and have the condition.
**P<0.05, subjects are less likely to have responded yes to the column’s question and have the condition.
BP, blood pressure; FH, family history; TM, tympanic membrane; Rx, prescription;
Synergistic role of technology-enabled screening (TES) in identifying at-risk or sick individuals
| Adolescent (18–19) | Young adult (20–39) | Middle age (40–64) | Old age (65–90) | Total (n =111) | ||||||
| RHS | TES | Female | Male | Female | Male | Female | Male | Female | Male | |
| ✓ | ✓ | 5 | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 10 |
| x | ✓ | 5 | 0 | 5 | 12 | 2 | 6 | 0 | 1 | 31 |
| ✓ | x | 4 | 0 | 5 | 4 | 5 | 3 | 0 | 1 | 22 |
| x | x | 5 | 0 | 3 | 7 | 9 | 15 | 2 | 7 | 48 |
| Total in age cohort | 19 | 0 | 16 | 23 | 16 | 26 | 2 | 9 | 111 | |
Check marks indicate normal status while x indicates abnormalities in a particular screening method.
RHS, routine health screenings; TES, technology-enabled screening.